Loading...
CRON logo

Cronos Group Inc.TSX:CRON Stock Report

Market Cap CA$1.3b
Share Price
CA$3.49
My Fair Value
CA$3.95
11.6% undervalued intrinsic discount
1Y15.6%
7D1.7%
Portfolio Value
​
View

Cronos Group Inc.

TSX:CRON Stock Report

Market Cap: CA$1.3b

Cronos Group (CRON) Stock Overview

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. More details

CRON fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 31.07% per year

Became profitable this year

Risk Analysis

No risks detected for CRON from our risk checks.

CRON Community Fair Values

Create Narrative

See what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.

CRON logo
Cronos Group

Global Cannabis Legalization Will Expand Wellness And Medicine Markets

Key Takeaways Strong premium brand portfolio, international expansion, and R&D investments position Cronos for sustainable margin growth and increased global market share as cannabis normalization accelerates. Robust financial health and strategic partnerships set Cronos up as a leading consolidator with significant upside from licensing, M&A, and new revenue streams.
View narrative
CA$5
FV
30.2% undervalued intrinsic discount
6.58%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
5 days ago author updated this narrative
CRON logo
Cronos Group

GrowCo Capacity And Global Markets Will Unlock Potential

Key Takeaways Expanded cultivation capacity and international market access are expected to drive revenue growth and increased market diversification. Strong brand performance and a shift to higher-margin products support improved profitability and margin expansion.
View narrative
CA$3.95
FV
11.6% undervalued intrinsic discount
6.46%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
11 days ago author updated this narrative
CRON logo
Cronos Group

Regulatory Shifts In Israel And Germany Will Hinder Cannabis Growth

Key Takeaways Reliance on international markets and regulatory uncertainty could threaten revenue growth and add financial volatility as legal or reimbursement environments shift. Intensifying price competition, ESG scrutiny, and rising operational costs may erode margin improvements and create challenges for sustained profitability.
View narrative
CA$2.9
FV
20.3% overvalued intrinsic discount
6.54%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
12 days ago author updated this narrative
View Stock Community

Cronos Group Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Cronos Group
Historical stock prices
Current Share PriceCA$3.49
52 Week HighCA$3.81
52 Week LowCA$2.27
Beta1.64
1 Month Change6.08%
3 Month Change34.75%
1 Year Change15.56%
3 Year Change-13.40%
5 Year Change-48.75%
Change since IPO320.48%

Recent News & Updates

Cronos Group Inc.'s (TSE:CRON) 26% Share Price Surge Not Quite Adding Up

Aug 15
Cronos Group Inc.'s (TSE:CRON) 26% Share Price Surge Not Quite Adding Up

Recent updates

Cronos Group Inc.'s (TSE:CRON) 26% Share Price Surge Not Quite Adding Up

Aug 15
Cronos Group Inc.'s (TSE:CRON) 26% Share Price Surge Not Quite Adding Up
User avatar

GrowCo Expansion Will Boost Operations But Strain Cash Flow

Investment in GrowCo and advancements in cannabis genetics are set to improve efficiency, enhance profitability, and strengthen market penetration.

We're Interested To See How Cronos Group (TSE:CRON) Uses Its Cash Hoard To Grow

May 31
We're Interested To See How Cronos Group (TSE:CRON) Uses Its Cash Hoard To Grow

Cronos Group Inc.'s (TSE:CRON) P/S Is Still On The Mark Following 29% Share Price Bounce

Apr 01
Cronos Group Inc.'s (TSE:CRON) P/S Is Still On The Mark Following 29% Share Price Bounce

We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Mar 02
We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Revenues Tell The Story For Cronos Group Inc. (TSE:CRON)

Feb 02
Revenues Tell The Story For Cronos Group Inc. (TSE:CRON)

Companies Like Cronos Group (TSE:CRON) Are In A Position To Invest In Growth

Nov 09
Companies Like Cronos Group (TSE:CRON) Are In A Position To Invest In Growth

We're Hopeful That Cronos Group (TSE:CRON) Will Use Its Cash Wisely

Jul 17
We're Hopeful That Cronos Group (TSE:CRON) Will Use Its Cash Wisely

Cronos Group Inc.'s (TSE:CRON) Earnings Haven't Escaped The Attention Of Investors

Jun 20
Cronos Group Inc.'s (TSE:CRON) Earnings Haven't Escaped The Attention Of Investors

We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Feb 09
We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)

Oct 12
A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)

We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate

Sep 10
We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate

Cronos Group Inc. (TSE:CRON) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Aug 12
Cronos Group Inc. (TSE:CRON) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

May 19
We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Is Cronos Group Inc. (TSE:CRON) Trading At A 47% Discount?

Jul 29
Is Cronos Group Inc. (TSE:CRON) Trading At A 47% Discount?

Shareholder Returns

CRONCA PharmaceuticalsCA Market
7D1.7%-6.3%1.1%
1Y15.6%-26.2%20.4%

Return vs Industry: CRON exceeded the Canadian Pharmaceuticals industry which returned -24.7% over the past year.

Return vs Market: CRON underperformed the Canadian Market which returned 21% over the past year.

Price Volatility

Is CRON's price volatile compared to industry and market?
CRON volatility
CRON Average Weekly Movement7.0%
Pharmaceuticals Industry Average Movement12.5%
Market Average Movement8.8%
10% most volatile stocks in CA Market18.3%
10% least volatile stocks in CA Market2.9%

Stable Share Price: CRON has not had significant price volatility in the past 3 months compared to the Canadian market.

Volatility Over Time: CRON's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a459Mike Gorensteinthecronosgroup.com

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.

Cronos Group Inc. Fundamentals Summary

How do Cronos Group's earnings and revenue compare to its market cap?
CRON fundamental statistics
Market capCA$1.34b
Earnings (TTM)CA$25.60m
Revenue (TTM)CA$180.39m
52.2x
P/E Ratio
7.4x
P/S Ratio

Is CRON overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CRON income statement (TTM)
RevenueUS$130.28m
Cost of RevenueUS$82.34m
Gross ProfitUS$47.94m
Other ExpensesUS$29.45m
EarningsUS$18.49m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.048
Gross Margin36.80%
Net Profit Margin14.19%
Debt/Equity Ratio0%

How did CRON perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/15 17:46
End of Day Share Price 2025/09/12 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cronos Group Inc. is covered by 18 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vahan AjamianBeacon Securities Limited
Tamy ChenBMO Capital Markets Equity Research
Matt BottomleyCanaccord Genuity